Efficacy and safety of lanreotide in combination with pegvisomant in clinical practice in patients with active acromegaly with monotherapy failure

Authors
Category Primary study
JournalEndocrine Reviews
Year 2013
This article has no abstract
Epistemonikos ID: b769147f0bf122c680e61a41bcda523e3094e307
First added on: Jul 02, 2024